This newslink doesn't exist or it was removed.
Go to Homempage.
The Hill USA Health January 27, 2023
How nostalgic are you willing to get? Starting this week, you can on your Nintendo Switch. New data from the CDC has found that the bivalent COVID boosters made available last September were no less effective at stopping symptomatic cases caused by the XBB.1.5 strain when... + más
New COVID-19 booster strengthens immune response against subvariants, Moderna says | The Boston Globe
Omicron Boosters Are Weaker Against BQ.1.1 Subvariant That Is Rising in U.S., Study Finds | NBC 6 South Florida
Forbes USA Tech December 06, 2022
3D illustration of a virus infection (coronavirus, viral pneumonia or influenza) and the risks of ... [+] complications for the urinary system (kidneys,bladder,ureter). Front view. Isolated on black background. getty A new finds that symptomatic Covid-19 infection is associated... + más
How Bladder Cancer Differs By Age and Sex | Time
Bladder Cancer Can Be Tough on Mental Health. Here's How to Cope | Time
New York Post USA Life January 27, 2023
Americans who got their COVID-19 bivalent booster vaccine are not fully protected against getting sick, according to a new report. The Centers for Disease Control and Prevention that said the updated boosters were just 48% effective at preventing symptomatic infection from the... + más
11.5M Americans have received updated COVID booster: CDC | ABC News
Thousands of Maine people per day getting their booster doses | Portland Press Herald
Politico USA Health January 26, 2023
A new CDC study has found that the Covid-19 bivalent booster reduces the risk of symptomatic infection from the most common subvariant circulating in the U.S. right now by about half. Additional new data, set to be published on the CDC website on Wednesday, also shows that... + más
Bivalent booster is 4x better against BA.5 in older adults, Pfizer says | Ars Technica
The Hill USA Health January 26, 2023
New data from the Centers for Disease Control and Prevention (CDC) indicates that the updated bivalent COVID-19 vaccines do not lose significant efficacy in preventing symptomatic coronavirus cases caused by the XBB.1.5 omicron subvariant when compared to previous strains. Data... + más
What we know about the new COVID-19 variant XBB | The Boston Globe
Highly Immune Evasive Omicron XBB.1.5 Variant Is Quickly Becoming Dominant in U.S. as It Doubles Weekly | NBC 6 South Florida
About iurex | Privacy Policy | Disclaimer |